Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1247677.RAejWVIaC_CyYFUIxgIRbvP80wtKpF47TeuCk4vkHB7p0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1247677.RAejWVIaC_CyYFUIxgIRbvP80wtKpF47TeuCk4vkHB7p0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1247677.RAejWVIaC_CyYFUIxgIRbvP80wtKpF47TeuCk4vkHB7p0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1247677.RAejWVIaC_CyYFUIxgIRbvP80wtKpF47TeuCk4vkHB7p0130_provenance.
- NP1247677.RAejWVIaC_CyYFUIxgIRbvP80wtKpF47TeuCk4vkHB7p0130_assertion description "[AAVrh.10BevMab, an AAVrh.10-based vector coding for bevacizumab (Avastin), an anti-human vascular endothelial growth factor (VEGF) monoclonal antibody, was delivered to the area of the GBM xenograft.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1247677.RAejWVIaC_CyYFUIxgIRbvP80wtKpF47TeuCk4vkHB7p0130_provenance.
- NP1247677.RAejWVIaC_CyYFUIxgIRbvP80wtKpF47TeuCk4vkHB7p0130_assertion evidence source_evidence_literature NP1247677.RAejWVIaC_CyYFUIxgIRbvP80wtKpF47TeuCk4vkHB7p0130_provenance.
- NP1247677.RAejWVIaC_CyYFUIxgIRbvP80wtKpF47TeuCk4vkHB7p0130_assertion SIO_000772 25501993 NP1247677.RAejWVIaC_CyYFUIxgIRbvP80wtKpF47TeuCk4vkHB7p0130_provenance.
- NP1247677.RAejWVIaC_CyYFUIxgIRbvP80wtKpF47TeuCk4vkHB7p0130_assertion wasDerivedFrom befree-2016 NP1247677.RAejWVIaC_CyYFUIxgIRbvP80wtKpF47TeuCk4vkHB7p0130_provenance.
- NP1247677.RAejWVIaC_CyYFUIxgIRbvP80wtKpF47TeuCk4vkHB7p0130_assertion wasGeneratedBy ECO_0000203 NP1247677.RAejWVIaC_CyYFUIxgIRbvP80wtKpF47TeuCk4vkHB7p0130_provenance.
- befree-2016 importedOn "2016-02-19" NP1247677.RAejWVIaC_CyYFUIxgIRbvP80wtKpF47TeuCk4vkHB7p0130_provenance.